CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial Bridging the Gap Between Epigenetic and Genetic in PAH Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Risk Stratification in PAH Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry 中国肺动脉高压诊断与治疗指南（2021版） Stress Echocardiography and PH: What Do the Findings Mean? Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease
|<< 1 2 3 4 5 6 7 8 >>|

Clinical Trial2016 Apr 21;374(16):1521-32.

JOURNAL：N Engl J Med. Article Link

Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

McMurray JJ, Krum H, ATMOSPHERE Committees Investigators. Keywords: chronic heart failure; HFrEF; outcome

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top